Recursion Pharmaceuticals, Inc. (RXRX)
4.74
-0.03
(-0.63%)
USD |
NASDAQ |
Dec 10, 11:30
Recursion Pharmaceuticals Shareholders Equity (Quarterly): 1.047B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Hims & Hers Health, Inc. | 580.98M |
| Eli Lilly & Co. | 23.79B |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Amicus Therapeutics, Inc. | 230.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.400B |
| Total Liabilities (Quarterly) | 352.58M |
| Debt to Equity Ratio | 0.0787 |
| Current Ratio | 4.604 |
| Net Debt Paydown Yield | 0.06% |